Cargando…
Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency
Malaria remains a major public health challenge with almost half of the world's population exposed to the risk of contracting the illness. Prompt, effective and well tolerated treatment remains one of the cornerstones in the disease management, with artemisinin-based combination therapy the rec...
Autores principales: | Pelfrene, Eric, Pinheiro, Marie-Hélène, Cavaleri, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492341/ https://www.ncbi.nlm.nih.gov/pubmed/25855638 http://dx.doi.org/10.1093/inthealth/ihv017 |
Ejemplares similares
-
The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
por: Pelfrene, Eric, et al.
Publicado: (2019) -
Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria in Uganda
por: Bukirwa, Hasifa, et al.
Publicado: (2006) -
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
por: Whegang, Solange Youdom, et al.
Publicado: (2010) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022) -
Adherence to Artemisinin Combination Therapy for the treatment of uncomplicated malaria in the Democratic Republic of the Congo
por: Siddiqui, M. Ruby, et al.
Publicado: (2015)